P3.01-043 Impact of ErbB Mutations on Clinical Outcomes in Afatinib- or Erlotinib-Treated Patients with SCC of the Lung
Makaleler > Tam Makale · 2017
Yazarlar: G. Goss, E. Felip, M. Cobo, S. Lu, K. Syrigos, K.H. Lee, Erdem GÖKER, V. Georgoulias, W. Li, S. Guclu, D. Isla, Y. Joo Min, A. Morabito, A. Ardizzoni, S. Gadgeel, N. Gibson, N. Krämer, F. Solca, A. Cseh, E. Ehrnrooth, J. Soria
Journal of Thoracic Oncology, Uluslararası, Wos, 2017, cilt 12, ss S2217-S2218